相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis
Jeehoon Kang et al.
EUROPEAN HEART JOURNAL (2023)
Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
Gjin Ndrepepa et al.
CLINICAL RESEARCH IN CARDIOLOGY (2022)
The Association between Low Levels of Low Density Lipoprotein Cholesterol and Intracerebral Hemorrhage: Cause for Concern?
Chen Gurevitz et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
Piotr Adamski et al.
JOURNAL OF CLINICAL MEDICINE (2022)
A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1
Angelo Zinellu et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Kai Song et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Comparison of Current International Guidelines for the Management of Dyslipidemia
Sevda Aygun et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell
Alessandro Morotti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study
Bernadeta Chyrchel et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor
Monica Verdoia et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2021)
Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin
Angelo Zinellu et al.
BIOMEDICINES (2021)
LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project
Qing Yang et al.
EUROPEAN HEART JOURNAL (2021)
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor
Monica Verdoia et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Influence of Cardiometabolic Risk Factors on Platelet Function
Cristina Barale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor
Monica Verdoia et al.
VASCULAR PHARMACOLOGY (2020)
De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
Daniel M. F. Claassens et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy
Rebecca B. Knowles et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
Annunziata Nusca et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation
Monica Verdoia et al.
JOURNAL OF CARDIOLOGY (2019)
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
Maximilian Tscharre et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
Bernhard Jaeger et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy
Elena Z. Golukhova et al.
CARDIOLOGY (2018)
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
Cristina Barale et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses
Zoltan Nagy et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
Dirk Sibbing et al.
LANCET (2017)
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
M. Verdoia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
Melissa V. Chan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The Dogged Search for Cryptic Effects of Ticagrelor Wishful Thinking or Real Benefits Beyond P2Y12 Inhibition?
Paul A. Gurbel et al.
CIRCULATION (2016)
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor
L. Barbieri et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2016)
Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
Monica Verdoia et al.
PLATELETS (2016)
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients
Matteo Nardin et al.
THROMBOSIS RESEARCH (2016)
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation
Monica Verdoia et al.
VASCULAR PHARMACOLOGY (2016)
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
Lucia Barbieri et al.
VASCULAR PHARMACOLOGY (2016)
Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade
Simbarashe Magwenzi et al.
BLOOD (2015)
Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
Dimitrios Alexopoulos et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Daniel Aradi et al.
EUROPEAN HEART JOURNAL (2015)
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor
Matteo Nardin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis
Dimitrios Alexopoulos et al.
AMERICAN HEART JOURNAL (2014)
Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance
Marco Cattaneo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
Udaya S. Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone et al.
LANCET (2013)
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Ticagrelor induces adenosine triphosphate release from human red blood cells
Jenny Ohman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model
J. J. J. van Giezen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
J. M. Siller-Matula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)
Willibald Hochholzer et al.
CIRCULATION (2011)
Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy
Bernadetta Chyrchel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia
B. Nagy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Adenosine and blood platelets
Hillary A. Johnston-Cox et al.
PURINERGIC SIGNALLING (2011)
Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
Olivier Muller et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade
Wayne Roberts et al.
BLOOD (2010)
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
A. Blum et al.
ATHEROSCLEROSIS (2009)
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention†
Raisuke Iijima et al.
EUROPEAN HEART JOURNAL (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
Matthew J. Price et al.
EUROPEAN HEART JOURNAL (2008)
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target
Paul A. Gurbel et al.
PLATELETS (2008)
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment
Dirk Sibbing et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Eugene A. Podrez et al.
NATURE MEDICINE (2007)
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin
M. Cattaneo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet nitric oxide responsiveness - A novel prognostic marker in acute coronary syndromes
SR Willoughby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway
E Mo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The adhesion molecule P-selectin and cardiovascular disease
AD Blann et al.
EUROPEAN HEART JOURNAL (2003)
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus
P Gresele et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Coexistence of impairment of endothelium-derived nitric oxide and platelet-derived nitric oxide in patients with coronary risk factors
A Katoh et al.
CIRCULATION JOURNAL (2002)
Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
F Mullershausen et al.
JOURNAL OF CELL BIOLOGY (2001)
Soluble P-selectin and the risk of future cardiovascular events
PM Ridker et al.
CIRCULATION (2001)
Platelet-derived nitric oxide and coronary risk factors
H Ikeda et al.
HYPERTENSION (2000)
分享论文
